Showing 1–3 of 3 results for author: Banaei, N

Rapid, antibiotic incubation-free determination of tuberculosis drug resistance using machine learning and Raman spectroscopy

Authors: Babatunde Ogunlade, Loza F. Tadesse, Hongquan Li, Nhat Vu, Niaz Banaei, Amy K. Barczak, Amr. A. E. Saleh, Manu Prakash, Jennifer A. Dionne

Abstract: Tuberculosis (TB) is the world's deadliest infectious disease, with over 1.5 million deaths annually and 10 million new cases reported each year. The causative organism, Mycobacterium tuberculosis (Mtb) can take nearly 40 days to culture, a required step to determine the pathogen's antibiotic susceptibility. Both rapid identification of Mtb and rapid antibiotic susceptibility testing (AST) are ess… ▽ More Tuberculosis (TB) is the world's deadliest infectious disease, with over 1.5 million deaths annually and 10 million new cases reported each year. The causative organism, Mycobacterium tuberculosis (Mtb) can take nearly 40 days to culture, a required step to determine the pathogen's antibiotic susceptibility. Both rapid identification of Mtb and rapid antibiotic susceptibility testing (AST) are essential for effective patient treatment and combating antimicrobial resistance. Here, we demonstrate a rapid, culture-free, and antibiotic incubation-free drug susceptibility test for TB using Raman spectroscopy and machine learning. We collect few-to-single-cell Raman spectra from over 25,000 cells of the MtB complex strain Bacillus Calmette Guerin (BCG) resistant to one of the four mainstay anti-TB drugs, isoniazid, rifampicin, moxifloxacin and amikacin, as well as a pan susceptible wildtype strain. By training a neural network on this data, we classify the antibiotic resistance profile of each strain, both on dried samples and in patient sputum samples. On dried samples, we achieve >98% resistant versus susceptible classification accuracy across all 5 BCG strains. In patient sputum samples, we achieve ~79% average classification accuracy. We develop a feature recognition algorithm in order to verify that our machine learning model is using biologically relevant spectral features to assess the resistance profiles of our mycobacterial strains. Finally, we demonstrate how this approach can be deployed in resource-limited settings by develo** a low-cost, portable Raman microscope that costs <$5000. We show how this instrument and our machine learning model enables combined microscopy and spectroscopy for accurate few-to-single-cell drug susceptibility testing of BCG. △ Less

Submitted 9 April, 2024; v1 submitted 8 June, 2023; originally announced June 2023.

Combining acoustic bioprinting with AI-assisted Raman spectroscopy for high-throughput identification of bacteria in blood

Authors: Fareeha Safir, Nhat Vu, Loza F. Tadesse, Kamyar Firouzi, Niaz Banaei, Stefanie S. Jeffrey, Amr A. E. Saleh, Butrus, Khuri-Yakub, Jennifer A. Dionne

Abstract: Identifying pathogens in complex samples such as blood, urine, and wastewater is critical to detect infection and inform optimal treatment. Surface-enhanced Raman spectroscopy (SERS) and machine learning (ML) can distinguish among multiple pathogen species, but processing complex fluid samples to sensitively and specifically detect pathogens remains an outstanding challenge. Here, we develop an ac… ▽ More Identifying pathogens in complex samples such as blood, urine, and wastewater is critical to detect infection and inform optimal treatment. Surface-enhanced Raman spectroscopy (SERS) and machine learning (ML) can distinguish among multiple pathogen species, but processing complex fluid samples to sensitively and specifically detect pathogens remains an outstanding challenge. Here, we develop an acoustic bioprinter to digitize samples into millions of droplets, each containing just a few cells, which are identified with SERS and ML. We demonstrate rapid printing of 2 pL droplets from solutions containing S. epidermidis, E. coli, and blood; when mixed with gold nanorods (GNRs), SERS enhancements of up to 1500x are achieved.We then train a ML model and achieve >=99% classification accuracy from cellularly-pure samples, and >=87% accuracy from cellularly-mixed samples. We also obtain >=90% accuracy from droplets with pathogen:blood cell ratios <1. Our combined bioprinting and SERS platform could accelerate rapid, sensitive pathogen detection in clinical, environmental, and industrial settings. △ Less

Submitted 6 March, 2023; v1 submitted 18 June, 2022; originally announced June 2022.

Comments: Minor correction to Fig. 2a caption to fix transposed label. Minor update to Supplementary Fig. 31, top figure, to correct the referenced plot

Rapid identification of pathogenic bacteria using Raman spectroscopy and deep learning

Authors: Chi-Sing Ho, Neal Jean, Catherine A. Hogan, Lena Blackmon, Stefanie S. Jeffrey, Mark Holodniy, Niaz Banaei, Amr A. E. Saleh, Stefano Ermon, Jennifer Dionne

Abstract: Rapid identification of bacteria is essential to prevent the spread of infectious disease, help combat antimicrobial resistance, and improve patient outcomes. Raman optical spectroscopy promises to combine bacterial detection, identification, and antibiotic susceptibility testing in a single step. However, achieving clinically relevant speeds and accuracies remains challenging due to the weak Rama… ▽ More Rapid identification of bacteria is essential to prevent the spread of infectious disease, help combat antimicrobial resistance, and improve patient outcomes. Raman optical spectroscopy promises to combine bacterial detection, identification, and antibiotic susceptibility testing in a single step. However, achieving clinically relevant speeds and accuracies remains challenging due to the weak Raman signal from bacterial cells and the large number of bacterial species and phenotypes. By amassing the largest known dataset of bacterial Raman spectra, we are able to apply state-of-the-art deep learning approaches to identify 30 of the most common bacterial pathogens from noisy Raman spectra, achieving antibiotic treatment identification accuracies of 99.0$\pm$0.1%. This novel approach distinguishes between methicillin-resistant and -susceptible isolates of Staphylococcus aureus (MRSA and MSSA) as well as a pair of isogenic MRSA and MSSA that are genetically identical apart from deletion of the mecA resistance gene, indicating the potential for culture-free detection of antibiotic resistance. Results from initial clinical validation are promising: using just 10 bacterial spectra from each of 25 isolates, we achieve 99.0$\pm$1.9% species identification accuracy. Our combined Raman-deep learning system represents an important proof-of-concept for rapid, culture-free identification of bacterial isolates and antibiotic resistance and could be readily extended for diagnostics on blood, urine, and sputum. △ Less

Submitted 5 November, 2019; v1 submitted 22 January, 2019; originally announced January 2019.

Journal ref: Nature Communications 10, 4927 (2019)